Searched for
ENZALUTAMIDE
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- Stocks in news: Angel One, Maruti Suzuki, Dabur, Marico, Aurobindo Pharma, ITCMaruti Suzuki reported a nearly 2% jump in September total sales at 1,84,727 units versus 1,81,343 units in the corresponding month of the ...
- BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...
- BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in IndiaThe company had earlier received approval from the Drugs Controller General of India (DCGI) to manufacture 40 mg enzalutamide in 2017 to tr...
- Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these ...
- Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.
- AI technique used to treat metastatic cancer patient: StudySingapore, Sep 2 (IANS) Singaporean researchers have harnessed the power of artificial intelligence (AI) to successfully treat a patient wi...
Load More